[HTML][HTML] Resistin, Elastase, and Lactoferrin as potential plasma biomarkers of Pediatric Inflammatory Bowel Disease based on Comprehensive Proteomic screens

ASCLS Titus, K Vanarsa, S Soomro, A Patel… - Molecular & Cellular …, 2023 - ASBMB
Inflammatory bowel disease (IBD) is an immune-mediated chronic inflammation of the
intestine, which can present in the form of ulcerative colitis (UC) or as Crohn's disease (CD) …

Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy

DO Riddell, JCW Hildyard… - Disease Models & …, 2022 - journals.biologists.com
Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disease, caused by
mutations in the dystrophin gene, characterised by cycles of muscle degeneration …

Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys

UJ Dang, M Ziemba, PR Clemens… - Human Molecular …, 2020 - academic.oup.com
Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin in muscle, and while
all patients share the primary gene and biochemical defect, there is considerable patient …

Ensemble modified aptamer based pattern recognition for adaptive target identification

J Chen, Y Xiang, P Wang, J Liu, W Lai, M Xiao… - Nano Letters, 2022 - ACS Publications
The difficulty of the molecular design and chemical synthesis of artificial sensing receptors
restricts their diagnostic and proteomic applications. Herein, we report a concept of …

miR-486 is essential for muscle function and suppresses a dystrophic transcriptome

A Samani, RM Hightower, AL Reid… - Life Science …, 2022 - life-science-alliance.org
miR-486 is a muscle-enriched microRNA, or “myomiR,” that has reduced expression
correlated with Duchenne muscular dystrophy (DMD). To determine the function of miR-486 …

[HTML][HTML] Phase 1 study of edasalonexent (CAT-1004), an oral NF-κB inhibitor, in pediatric patients with Duchenne muscular dystrophy

E Finanger, K Vandenborne, RS Finkel… - Journal of …, 2019 - content.iospress.com
Background: Edasalonexent is an orally administered small molecule designed to inhibit NF-
κB, which is activated from infancy in Duchenne muscular dystrophy and is central to …

[HTML][HTML] Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy

Y Hathout, C Liang, M Ogundele, G Xu, SM Tawalbeh… - Scientific reports, 2019 - nature.com
Extensive biomarker discoveries for DMD have occurred in the past 7 years, and a vast array
of these biomarkers were confirmed in independent cohorts and across different …

Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle

P Dowling, S Gargan, M Zweyer, H Sabir… - Expert review of …, 2021 - Taylor & Francis
Introduction Carbonic anhydrase (CA) is a key enzyme that mediates the reversible
hydration of carbon dioxide. Skeletal muscles contain high levels of the cytosolic isoform …

[HTML][HTML] Trained immunity as a potential target for therapeutic immunomodulation in Duchenne muscular dystrophy

BJ Petrof, T Podolsky, S Bhattarai, J Tan… - Frontiers in …, 2023 - frontiersin.org
Dysregulated inflammation involving innate immune cells, particularly of the monocyte/
macrophage lineage, is a key contributor to the pathogenesis of Duchenne muscular …

The relationship of circulating proteins in early pregnancy with preterm birth

AM Lynch, BD Wagner, RR Deterding, PC Giclas… - American journal of …, 2016 - Elsevier
Background Preterm birth (PTB)(< 37 completed weeks' gestation) is a pathological outcome
of pregnancy and a major global health problem. Babies born preterm have an elevated risk …